Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Brain, Behavior, and Immunity
|
July 7, 2020
Where there's smoke, there's fire: Cannabis, P2RX7 and inflammatory pathways intersect to increase psychosis susceptibility
David R Goldsmith
Brain, Behavior, and Immunity
|
April 26, 2024
The psychoneuroimmunology of Psychosis: Peeking past the clouds of Heterogeneity: Editorial
Rachel Upthegrove, David R Goldsmith
Drugs & Aging
|
December 6, 2005
Naftidrofuryl: a review of its use in the treatment of intermittent claudication
David R Goldsmith, Keri Wellington
Harvard Review of Psychiatry
|
January 7, 2022
Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
David S Thylur, David R Goldsmith
Schizophrenia Research
|
January 29, 2022
Schizophrenia: A scientific graveyard or a pragmatically useful diagnostic construct?
Elaine F Walker, David R Goldsmith
Drugs
|
August 9, 2003
Atazanavir
David R Goldsmith, Caroline M Perry
Drugs & Aging
|
December 4, 2003
Donepezil: in vascular dementia
David R Goldsmith, Lesley J Scott
Psychiatria Danubina
|
October 18, 2022
The Tortoise Beats the Hare: The Case for Slow Clozapine Titrations with Serial CRP Monitoring
Robert O Cotes, David R Goldsmith
Drugs
|
August 27, 2004
Amphotericin B lipid complex: in visceral leishmaniasis
David R Goldsmith, Caroline M Perry
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 27, 2006
Spotlight on mammalian cell-derived somatropin in HIV-associated wasting
David R Goldsmith, Antona J Wagstaff
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Brain, Behavior, and Immunity
|
July 7, 2020
Where there's smoke, there's fire: Cannabis, P2RX7 and inflammatory pathways intersect to increase psychosis susceptibility
David R Goldsmith
Brain, Behavior, and Immunity
|
April 26, 2024
The psychoneuroimmunology of Psychosis: Peeking past the clouds of Heterogeneity: Editorial
Rachel Upthegrove, David R Goldsmith
Drugs & Aging
|
December 6, 2005
Naftidrofuryl: a review of its use in the treatment of intermittent claudication
David R Goldsmith, Keri Wellington
Harvard Review of Psychiatry
|
January 7, 2022
Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
David S Thylur, David R Goldsmith
Schizophrenia Research
|
January 29, 2022
Schizophrenia: A scientific graveyard or a pragmatically useful diagnostic construct?
Elaine F Walker, David R Goldsmith
Drugs
|
August 9, 2003
Atazanavir
David R Goldsmith, Caroline M Perry
Drugs & Aging
|
December 4, 2003
Donepezil: in vascular dementia
David R Goldsmith, Lesley J Scott
Psychiatria Danubina
|
October 18, 2022
The Tortoise Beats the Hare: The Case for Slow Clozapine Titrations with Serial CRP Monitoring
Robert O Cotes, David R Goldsmith
Drugs
|
August 27, 2004
Amphotericin B lipid complex: in visceral leishmaniasis
David R Goldsmith, Caroline M Perry
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 27, 2006
Spotlight on mammalian cell-derived somatropin in HIV-associated wasting
David R Goldsmith, Antona J Wagstaff
Page
of 8